IRIS
REFINI, ROSA METELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.580
NA - Nord America 4.230
AS - Asia 719
AF - Africa 17
SA - Sud America 10
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 3
Totale 9.563
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.211
IT - Italia 1.283
GB - Regno Unito 1.053
IE - Irlanda 723
CN - Cina 426
SE - Svezia 385
RU - Federazione Russa 277
UA - Ucraina 269
DE - Germania 186
FR - Francia 175
SG - Singapore 150
FI - Finlandia 102
TR - Turchia 51
ES - Italia 45
VN - Vietnam 32
CZ - Repubblica Ceca 26
BE - Belgio 17
CA - Canada 17
IN - India 17
CI - Costa d'Avorio 11
IR - Iran 9
PK - Pakistan 9
PT - Portogallo 6
AT - Austria 5
AU - Australia 4
BR - Brasile 4
AL - Albania 3
CH - Svizzera 3
DK - Danimarca 3
EU - Europa 3
GR - Grecia 3
HK - Hong Kong 3
KZ - Kazakistan 3
MA - Marocco 3
PL - Polonia 3
AR - Argentina 2
AZ - Azerbaigian 2
BG - Bulgaria 2
EC - Ecuador 2
IS - Islanda 2
JP - Giappone 2
KG - Kirghizistan 2
LV - Lettonia 2
MX - Messico 2
PH - Filippine 2
RO - Romania 2
AE - Emirati Arabi Uniti 1
BD - Bangladesh 1
BH - Bahrain 1
CL - Cile 1
CY - Cipro 1
EG - Egitto 1
HU - Ungheria 1
ID - Indonesia 1
IL - Israele 1
JO - Giordania 1
KR - Corea 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
MK - Macedonia 1
NG - Nigeria 1
NL - Olanda 1
PE - Perù 1
SA - Arabia Saudita 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
ZA - Sudafrica 1
Totale 9.563
Salva come PNG Salva come JPEG
Città #
Southend 989
Dublin 715
Fairfield 675
Chandler 401
Ashburn 334
Woodbridge 302
Seattle 279
Houston 248
Siena 234
Wilmington 231
Jacksonville 223
Cambridge 213
Ann Arbor 155
Beijing 121
Princeton 119
Singapore 118
Dearborn 96
New York 69
Lastra a Signa 68
Helsinki 65
Nanjing 60
Boardman 54
Gavirate 48
Florence 46
San Mateo 45
Izmir 44
Málaga 44
San Diego 35
Nanchang 33
Dong Ket 32
Moscow 32
Shanghai 32
Milan 31
Catania 28
Rome 27
Fremont 23
Munich 19
Brussels 17
Changsha 17
Hebei 17
London 16
Brno 14
Guangzhou 14
Hefei 13
Shenyang 13
Kunming 12
Menlo Park 12
Norwalk 12
Abidjan 11
Hangzhou 11
Olomouc 11
Prato 11
Jiaxing 10
Trieste 10
Lahore 9
Lancaster 9
Montecatini Terme 9
Ningbo 9
San Francisco 9
Tianjin 9
Washington 9
Zhengzhou 9
Arezzo 8
Figline Valdarno 8
Napoli 8
Düsseldorf 7
Los Angeles 7
Sesto Fiorentino 7
Duncan 6
Grosseto 6
Redwood City 6
Venezia 6
Zanjan 6
Chicago 5
Dallas 5
Genoa 5
Genova 5
Livorno 5
Naples 5
Ponte Buggianese 5
Saint Louis 5
Agliana 4
Bergamo 4
Bologna 4
Empoli 4
Grünheide 4
Jinan 4
Kilburn 4
Montespertoli 4
Ottawa 4
Pisa 4
Santa Clara 4
Sovicille 4
Toronto 4
Vienna 4
Almaty 3
Anguillara Sabazia 3
Atlanta 3
Bari 3
Bonndorf 3
Totale 6.767
Salva come PNG Salva come JPEG
Nome #
La chitotriosidasi: un sensibile biomarker di sarcoidosi 958
Alveolar concentration of nitric oxide as a prognostic biomarker in idiopathic pulmonary fibrosis 200
Bronchoalveolar lavage proteomic analysis in pulmonary fibrosis associated with systemic sclerosis: S100A6 and 14-3-3ε as potential biomarkers 194
Chitotriosidase: a biomarker of activity and severity in patients with sarcoidosis 189
Exhaled nitric oxide in interstitial lung diseases 188
A system biology study of BALF from patients affected by idiopathic pulmonary fibrosis (IPF) and healthy controls 186
Idiopathic pulmonary fibrosis a rare disease with severe bone fragility 185
Posttransplant solid organ malignancies in lung transplant recipients: A single-center experience and review of the literature 183
Familial pulmonary fibrosis: Clinical and radiological characteristics and progression analysis in different high resolution-CT patterns 181
Diagnosis of idiopathic pulmonary fibrosis by virtual means using “IPFdatabase”- a new software 181
Elevated level of Galectin-1 in bronchoalveolar lavage of patients with idiopathic pulmonary fibrosis 176
Pulmonary hypertension in idiopathic pulmonary fibrosis: prevalence and clinical progress 168
Mortality on the Waiting List for Lung Transplantation in Patients with Idiopathic Pulmonary Fibrosis: A Single-Centre Experience 166
Evaluation of multiple-flows exhaled nitric oxide in idiopathic and non-idiopathic interstitial lung disease 166
The effect of cigarette smoking on bronchoalveolar lavage protein profiles from patients with different interstitial lung diseases 166
Different effects of inhaled aspirinlike drugs on allergen-induced early and late asthmatic responses 163
Role of BNP and echo measurement for pulmonary hypertension recognition in patients with interstitial lung disease: An algorithm application model 163
Sildenafil in severe pulmonary hypertension associated with chronic obstructive pulmonary disease: A randomized controlled multicenter clinical trial 160
Inhaled PGE2 prevents aspirin-induced bronchoconstriction and urinary LTE4 excretion in aspirin-sensitive asthma 153
NK and NKT-like cells in granulomatous and fibrotic lung diseases 152
Serum analysis of coagulation factors in IPF and NSIP 150
Pirfenidone therapy for familial pulmonary fibrosis: a real-life study. 150
Protective effect of inhaled furosemide on allergen-induced early and late asthmatic reactions 149
Could NSAIDs have a role as antiasthmatic agents? 144
null 143
Prognostic bioindicators in severe COVID-19 patients 139
Steroid-sparing effect of inhaled lysine acetylsalicylate and furosemide in high-dose beclomethasone-dependent asthma 138
Calgranulin B (S100A9/MRP14): a Key molecule in idiopathic pulmonary fibrosis? 133
Proteomic investigation of pulmonary sarcoidosis 128
Efficacy and tolerability of nimesulide in asthmatic patients intolerant to aspirin 127
Postoperative acute kidney injury in lung transplant recipients 126
Omalizumab treatment in Samter's triad: case series and review of the literature 124
Attenuation of aspirin-induced bronchoconstriction by sodium cromoglycate and nedocromil sodium 123
null 121
P172 Pulmonary Hypertension In Ipf: Utility Of Hrct 121
The Role of Urinary Calcium and Chitotriosidase in a Cohort of Chronic Sarcoidosis Patients 121
Time-limited protective effect of inhaled frusemide against aspirin-induced bronchoconstriction in aspirin-sensitive asthmatics 120
Serum KL-6 concentrations as a novel biomarker of severe COVID-19 118
New concepts in the pathogenesis of sarcoidosis 117
Alveolar nitric oxide is related to periostin levels in idiopathic pulmonary fibrosis 117
Regulatory T Cells in Severe Persistent Asthma in the Era of Monoclonal Antibodies Target Therapies 117
IPF mortality in waiting list for lung transplantation 116
Pirfenidone in idiopathic pulmonary fibrosis: real-life experience in the referral centre of Siena 116
Helicobacter pylori seroprevalence in patients with idiopathic pulmonary fibrosis 114
Adaptive immune system in pulmonary sarcoidosis - comparison of peripheral and alveolar biomarkers 113
Exhaled carbon monoxide in sarcoidosis 112
Protective activity of inhaled nonsteroidal antiinflammatory drugs on bronchial responsiveness to ultrasonically nebulized water 110
Helicobacter pylori Infection Does Not Impact on Lung Transplant Outcome 108
Utility of spiral CAT scan in the follow-up of patients with pulmonary Largerhans cell histiocytosis 107
Coronavirus HKU 1 infection with bronchiolitis, pericardial effusion and acute respiratory failure in obese adult female 107
null 106
Inhaled loop diuretics as potential new anti-asthmatic drugs 104
Valutazione dell'ossido nitrico nell'esalato delle polmoniti interstiziali idiopatiche 104
Mortalità in lista per trapianto di polmone in pazienti affetti da fibrosi polmonare idiopatica 103
Chitotriosidase: a sensitive biomarker of sarcoidosis 102
Efficacy of baricitinib in treating rheumatoid arthritis: Modulatory effects on fibrotic and inflammatory biomarkers in a real-life setting 100
Potentiation of the antireactive, antiasthmatic effect of inhaled furosemide by inhaled lysine acetylsalicylate 94
Immunologic responses to antifibrotic treatment in IPF patients 91
Familial pulmonary fibrosis: Clinical-functional and radiological features 88
Exhaled carbon monoxide in sarcoidosis 83
Peripheral and alveolar biomarkers of fibrotic hypersensitivity pneumonitis 81
A functional proteomics approach to the comprehension of sarcoidosis 72
Hypercalciuria in Sarcoidosis: A Specific Biomarker With Clinical Utility 72
null 63
Acute exacerbation of idiopathic pulmonary fibrosis after inhalation of a water repellent 63
Exhaled nitric oxide and carbon monoxide in lung transplanted patients 55
Chitotriosidase analysis in bronchoalveolar lavage of patients with sarcoidosis. 55
Cytomegalovirus Infection Is Associated with Development of Chronic Lung Allograft Dysfunction 42
Immune checkpoint analysis of T-cell responses to pp65 and IE-1 antigens in end-stage lung diseases 37
Exploring the interaction between fractional exhaled nitric oxide and biologic treatment in severe asthma: a systematic review 37
The effectiveness of nintedanib in patients with idiopathic pulmonary fibrosis, familial pulmonary fibrosis and progressive fibrosing interstitial lung diseases: a real-world study 34
Calgranulin B and KL-6 in Bronchoalveolar Lavage of Patients with IPF and NSIP 25
Calgranulin B/S100A9 and KL-6 in bronchoalveolar lavage of patients with IPF and NSIP 24
Human chitotriosidase analysis: a reliable biomarker of sarcoidosis severity 22
Serum and BAL levels of KL6 in chronic hypersensitivity pneumonitis Serum and BAL levels of KL6 in chronic hypersensitivity pneumonitis 21
Nintedanib in Idiopathic Pulmonary Fibrosis: a single-centre real-life experience 20
Real-life comparison between pirfenidone and nintedanib in patients with idiopathic pulmonary fibrosis 20
Serum concentrations of KL-6 in patients with IPF and lung cancer and serial measurements of KL-6 in IPF patients treated with antifibrotic therapy 13
The value of urinary calcium as biomarker in chronic sarcoidosis 13
Erratum: Chitotriosidase: a biomarker of activity and severity in patients with sarcoidosis (Respiratory Research (2020) 21 (6) DOI: 10.1186/s12931-019-1263-z) 12
Esperienza in real-life della terapia con Pirfenidone in pazienti affetti da IPF. 5
Evaluation of exhaled nitric oxide in idiopathic interstitial lung diseases 3
Esperienza in real-life della terapia con Pirfenidone in pazienti affetti da IPF. 2
Totale 9.773
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.168
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.168
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.302 0 0 0 0 132 196 214 227 178 169 68 118
2020/20211.550 58 157 43 132 159 194 113 206 116 133 132 107
2021/20221.055 72 133 79 93 54 30 49 43 35 108 150 209
2022/20231.358 87 140 163 169 136 245 50 108 140 58 38 24
2023/20241.218 39 21 105 54 59 311 407 36 8 39 21 118
2024/2025604 135 100 249 78 42 0 0 0 0 0 0 0
Totale 9.773